2010Zhongliu fangzhi yanjiuOpen access

Expression and Clinical Significance of CEA mRNA in Peripheral Blood of Non-small Cell Lung Cancer Patients

Kai Ding

Open full text 0 citations

Abstract

Objective To detect CEA expression in peripheral blood of non-small lung cancer(NSCLC) patients and discuss the possibility of indicating NSCLC micrometastases by it.Methods The expression of CEA mRNA was analyzed by RT-PCR in 48 NSCLC in peripheral blood,compared with 15 patients with benign lung disease(BLD)and 10 healthy volunteers.Results The positive expression rate of CEA mRNA was significantly higher in NSCLC than in those of BLD and healthy volunteers(P0.01).The expression rate of CEA mRNA was 27.8%,83.3%,61.5%,100% in peripheral blood with non-small cell lung cancer of TNM stageⅠ~Ⅳrespectively.The positive expression of CEA was closely related with the clinical staging and lymph node metastasis(P0.05),but not related to pathological type and tumor cell differentiation(P0.05).Conclusion Expressions of CEA mRNA in peripheral blood can be used as a valuable biomarker for diagnosis of micrometastasis in patients with NSCLC.

About this research paper

What this paper is about

Objective To detect CEA expression in peripheral blood of non-small lung cancer(NSCLC) patients and discuss the possibility of indicating NSCLC micrometastases by it.Methods The expression of CEA mRNA was analyzed by RT-PCR in 48 NSCLC in peripheral blood,compared with 15 patients with benign lung disease(BLD)and 10 healthy volunteers.Results The positive expression rate of CEA mRNA was significantly higher in NSCLC than in those of BLD and healthy volunteers(P0.01).The expression rate of CEA mRNA was 27.8%,83.3%,61.5%,100% in peripheral blood with non-small cell lung cancer of TNM stageⅠ~Ⅳrespectively.The positive expression of CEA was closely related with the clinical staging and lymph node metastasis(P0.05),but not related to pathological type and tumor cell differentiation(P0.05).Conclusion Expressions of CEA mRNA in peripheral blood can be used as a valuable biomarker for diagnosis of micrometastasis in patients with NSCLC.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To detect CEA expression in peripheral blood of non-small lung cancer(NSCLC) patients and discuss the possibility of indicating NSCLC micrometastases by it.Methods The expression of CEA mRNA was analyzed by RT-PCR in 48 NSCLC in peripheral blood,compared with 15 patients with benign lung disease(BLD)and 10 healthy volunteers.Results The positive expression rate of CEA mRNA was significantly higher in NSCLC than in those of BLD and healthy volunteers(P0.01).The expression rate of CEA mRNA was 27.8%,83.3%,61.5%,100% in peripheral blood with non-small cell lung cancer of TNM stageⅠ~Ⅳrespectively.The positive expression of CEA was closely related with the clinical staging and lymph node metastasis(P0.05),but not related to pathological type and tumor cell differentiation(P0.05).Conclusion Expressions of CEA mRNA in peripheral blood can be used as a valuable biomarker for diagnosis of micrometastasis in patients with NSCLC.

Key concepts: Micrometastasis, Medicine, Lung cancer, Stage (stratigraphy), Peripheral blood, Clinical significance, Pathological, Oncology

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression and Clinical Significance of CEA mRNA in Peripheral Blood of Non-small Cell Lung Cancer Patients — Research Paper | ScholarLens